26th Oct 2016 12:00 pm |
RNS |
3rd Quarter Results |
25th Oct 2016 2:12 pm |
RNS |
Director/PDMR Shareholding |
24th Oct 2016 7:00 am |
RNS |
US FDA submission of shingles candidate vaccine |
21st Oct 2016 4:12 pm |
RNS |
Director/PDMR Shareholding |
18th Oct 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
18th Oct 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
18th Oct 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
18th Oct 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
17th Oct 2016 6:28 pm |
RNS |
Director/PDMR Shareholding |
17th Oct 2016 6:21 pm |
RNS |
Director/PDMR Shareholding |
17th Oct 2016 6:17 pm |
RNS |
Director/PDMR Shareholding |
14th Oct 2016 5:27 pm |
RNS |
Director/PDMR Shareholding |
14th Oct 2016 5:13 pm |
RNS |
Director/PDMR Shareholding |
14th Oct 2016 5:10 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2016 5:27 pm |
RNS |
Director/PDMR Shareholding |
10th Oct 2016 4:47 pm |
RNS |
Director/PDMR Shareholding |
3rd Oct 2016 10:03 am |
RNS |
Total Voting Rights |
29th Sep 2016 10:17 am |
RNS |
Director/PDMR Shareholding |
29th Sep 2016 7:54 am |
RNS |
GSK completes sale of holding in Aspen |
28th Sep 2016 4:19 pm |
RNS |
GSK intends to sell remaining holding in Aspen |
26th Sep 2016 5:02 pm |
RNS |
Director/PDMR Shareholding |
26th Sep 2016 4:56 pm |
RNS |
Director/PDMR Shareholding |
23rd Sep 2016 1:00 pm |
RNS |
US Regulatory Submission for sirukumab in RA |
20th Sep 2016 7:00 am |
RNS |
GSK Appoints New CEO |
19th Sep 2016 3:13 pm |
RNS |
Director/PDMR Shareholding |
15th Sep 2016 7:00 am |
RNS |
Results Phase III Study Shingrix Vaccine in NEJM |
12th Sep 2016 4:58 pm |
RNS |
Director/PDMR Shareholding |
12th Sep 2016 12:33 pm |
RNS |
EU regulatory submission for sirukumab in RA |
6th Sep 2016 2:49 pm |
RNS |
Results of Phase III FULFIL Study Presented at ERS |
5th Sep 2016 7:00 am |
RNS |
Positive Results from the COPD Salford Lung Study |
1st Sep 2016 2:42 pm |
RNS |
Total Voting Rights |
30th Aug 2016 12:36 pm |
RNS |
Director/PDMR Shareholding |
23rd Aug 2016 3:45 pm |
RNS |
Director/PDMR Shareholding |
16th Aug 2016 3:07 pm |
RNS |
Director/PDMR Shareholding |
16th Aug 2016 1:07 pm |
RNS |
ViiV starts PhIII Programme for dolutegravir & 3TC |
12th Aug 2016 4:08 pm |
RNS |
Director/PDMR Shareholding |
10th Aug 2016 2:45 pm |
RNS |
Director/PDMR Shareholding |
9th Aug 2016 5:43 pm |
RNS |
Director/PDMR Shareholding |
4th Aug 2016 3:49 pm |
RNS |
Publication of a Prospectus |
1st Aug 2016 3:26 pm |
RNS |
Director/PDMR Shareholding |